Literature DB >> 35414420

The canonical pattern of Alzheimer's disease atrophy is linked to white matter hyperintensities in normal controls, differently in normal controls compared to in AD.

Joost M Riphagen1, Mahanand Belathur Suresh2, David H Salat3.   

Abstract

White matter signal abnormalities (WMSA), either hypo- or hyperintensities in MRI imaging, are considered a proxy of cerebrovascular pathology and contribute to, and modulate, the clinical presentation of Alzheimer's disease (AD), with cognitive dysfunction being apparent at lower levels of amyloid and/or tau pathology when lesions are present. To what extent the topography of cortical thinning associated with AD may be explained by WMSA remains unclear. Cortical thickness group difference maps and subgroup analyses show that the effect of WMSA on cortical thickness in cognitively normal participants has a higher overlap with the canonical pattern of AD, compared to AD participants. (Age and sex-matched group of 119 NC (AV45 PET negative, CDR = 0) versus 119 participants with AD (AV45 PET-positive, CDR > 0.5). The canonical patterns of cortical atrophy thought to be specific to Alzheimer's disease are strongly linked to cerebrovascular pathology supporting a reinterpretation of the classical models of AD suggesting that a part of the typical AD pattern is due to co-localized cortical loss before the onset of AD.
Copyright © 2022. Published by Elsevier Inc.

Entities:  

Keywords:  Aging; Alzheimer's disease; Cortical thickness; Vascular risk; White matter hyperintensities

Mesh:

Year:  2022        PMID: 35414420      PMCID: PMC9387174          DOI: 10.1016/j.neurobiolaging.2022.02.008

Source DB:  PubMed          Journal:  Neurobiol Aging        ISSN: 0197-4580            Impact factor:   5.133


  59 in total

1.  Vascular imaging abnormalities and cognition: mediation by cortical volume in nondemented individuals: atherosclerosis risk in communities-neurocognitive study.

Authors:  David S Knopman; Michael E Griswold; Seth T Lirette; Rebecca F Gottesman; Kejal Kantarci; A Richey Sharrett; Clifford R Jack; Jonathan Graff-Radford; Andrea L C Schneider; B Gwen Windham; Laura H Coker; Marilyn S Albert; Thomas H Mosley
Journal:  Stroke       Date:  2015-01-06       Impact factor: 7.914

2.  Gray matter reduction is correlated with white matter hyperintensity volume: a voxel-based morphometric study in a large epidemiological sample.

Authors:  Wei Wen; Perminder S Sachdev; Xiaohua Chen; Kaarin Anstey
Journal:  Neuroimage       Date:  2005-10-25       Impact factor: 6.556

3.  White matter hyperintensities and cerebral amyloidosis: necessary and sufficient for clinical expression of Alzheimer disease?

Authors:  Frank A Provenzano; Jordan Muraskin; Giuseppe Tosto; Atul Narkhede; Ben T Wasserman; Erica Y Griffith; Vanessa A Guzman; Irene B Meier; Molly E Zimmerman; Adam M Brickman
Journal:  JAMA Neurol       Date:  2013-04       Impact factor: 18.302

4.  Diffusion tensor MRI correlates with executive dysfunction in patients with ischaemic leukoaraiosis.

Authors:  M O'Sullivan; R G Morris; B Huckstep; D K Jones; S C R Williams; H S Markus
Journal:  J Neurol Neurosurg Psychiatry       Date:  2004-03       Impact factor: 10.154

5.  Neuropathologic basis of white matter hyperintensity accumulation with advanced age.

Authors:  Deniz Erten-Lyons; Randall Woltjer; Jeffrey Kaye; Nora Mattek; Hiroko H Dodge; Sarah Green; Huong Tran; Diane B Howieson; Katherine Wild; Lisa C Silbert
Journal:  Neurology       Date:  2013-08-09       Impact factor: 9.910

6.  The Alzheimer's Disease Neuroimaging Initiative (ADNI): MRI methods.

Authors:  Clifford R Jack; Matt A Bernstein; Nick C Fox; Paul Thompson; Gene Alexander; Danielle Harvey; Bret Borowski; Paula J Britson; Jennifer L Whitwell; Chadwick Ward; Anders M Dale; Joel P Felmlee; Jeffrey L Gunter; Derek L G Hill; Ron Killiany; Norbert Schuff; Sabrina Fox-Bosetti; Chen Lin; Colin Studholme; Charles S DeCarli; Gunnar Krueger; Heidi A Ward; Gregory J Metzger; Katherine T Scott; Richard Mallozzi; Daniel Blezek; Joshua Levy; Josef P Debbins; Adam S Fleisher; Marilyn Albert; Robert Green; George Bartzokis; Gary Glover; John Mugler; Michael W Weiner
Journal:  J Magn Reson Imaging       Date:  2008-04       Impact factor: 4.813

7.  White matter hyperintensities are positively associated with cortical thickness in Alzheimer's disease.

Authors:  Heidi I L Jacobs; Lies Clerx; Ed H B M Gronenschild; Pauline Aalten; Frans R J Verhey
Journal:  J Alzheimers Dis       Date:  2014       Impact factor: 4.472

8.  Normal-appearing white matter in ischemic leukoaraiosis: a diffusion tensor MRI study.

Authors:  M O'Sullivan; P E Summers; D K Jones; J M Jarosz; S C Williams; H S Markus
Journal:  Neurology       Date:  2001-12-26       Impact factor: 9.910

9.  Serum neurofilament light is sensitive to active cerebral small vessel disease.

Authors:  Thomas Gattringer; Daniela Pinter; Christian Enzinger; Thomas Seifert-Held; Markus Kneihsl; Simon Fandler; Alexander Pichler; Christian Barro; Svenya Gröbke; Margarete Voortman; Lukas Pirpamer; Edith Hofer; Stefan Ropele; Reinhold Schmidt; Jens Kuhle; Franz Fazekas; Michael Khalil
Journal:  Neurology       Date:  2017-10-18       Impact factor: 9.910

10.  White matter hyperintensity topography in Alzheimer's disease and links to cognition.

Authors:  Antoine Garnier-Crussard; Salma Bougacha; Miranka Wirth; Sophie Dautricourt; Siya Sherif; Brigitte Landeau; Julie Gonneaud; Robin De Flores; Vincent de la Sayette; Denis Vivien; Pierre Krolak-Salmon; Gaël Chételat
Journal:  Alzheimers Dement       Date:  2021-07-28       Impact factor: 16.655

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.